Table 1.
Characteristics and experimental results of the study population
| Parameter | Data (n = 371) |
|---|---|
| Gestational age, wk | 39.05 ± 2.31 |
| 1 d | 50/371 (13.5%) |
| 2‐7 d | 105/371 (28.3%) |
| 8‐28 d | 216/371 (58.2%) |
| Body weight, g | 3280 ± 459 |
| Gender (female) | 135/371 (36.4%) |
| Spontaneous partum | 158/371 (42.6%) |
| Caesarean section | 213/371 (57.4%) |
| R | 4.80 (2.80‐7.17) |
| Angle | 69.90 (44.73‐78.88) |
| K | 1.40 (0.80‐4.57) |
| MA | 63.30 (43.92‐74.65) |
| LY30 | 0.10 (0.10‐6.94) |
| TT | 19.60 (16.43‐25.40) |
| APTT | 49.80 (32.68‐86.75) |
| PT | 13.10 (10.60‐18.27) |
| Fib | 2.21 (1.05‐5.12) |
| PLT | 321.00 (120.50‐623.70) |
Demographic and clinical data were expressed as the mean ± standard deviation, or no. (%). Data of TEG parameters and coagulation test parameters are presented as medians and reference ranges (2.5th and 97.5th percentiles). R (s), K (s), Angle (α), maximum amplitude (MA, mm), and lysis at 30 min (LY30, %), thromboplastin time (TT, s), activated partial thromboplastin time (APTT, s), prothrombin time (PT, s), and fibrinogen (Fib, g/L), platelet count (PLT, 109/L).